GSK and ViiV Healthcare are committed to providing innovative medicines for people living with HIV. Here you can access the latest information on our HIV portfolio.
▼These medicinal products are subject to additional monitoring.
- Llibre JM, Walmsley S, Gatell JM. Backbones versus core agents in initial ART regimens: one game, two players. J Antimicrob. Chemother. (2016); 71 (4): 856-861.